Procter & Gamble (PCGL) Q1 2027 Earnings Report

The call was broadly positive. P&G reported 4.0% organic sales growth, volume-led momentum across all categories and regions, improving share trends, strong performance in North America and China, and maintained its fiscal 2027 guidance. However, the outlook includes significant commodity, freight, foreign-exchange, interest, and geopolitical headwinds, along with margin pressure, flat aggregate market share, and unresolved challenges in several categories. Management remained confident in the company's ability to execute, but emphasized that results would be volatile and would not progress in a straight line.

For fiscal 2027, P&G is maintaining guidance for sales growth of 1% to 3%, core EPS growth of 0% to 3% versus prior year, or $6.89 to $7.11 per share, and free cash flow productivity at 85% to 90%; top line guidance includes roughly 30% to 50% basis points headwinds from product and market exits, the outlook includes a cost headwind of approximately $1.4 billion after tax assuming an effective Brent crude oil price of $100 a barrel, an expected foreign exchange headwind of approximately $50 million after tax, approximately $300 million of higher net interest expense after tax, around €150 million higher due to debt issuance related to recent M&A activity, and $150 million after tax of lower non operating income; the core effective tax rate is expected to be in the range of 20% to 21%, combined input costs, foreign exchange items below the operating line are expected to be roughly $1.9 billion after tax headwind of earnings, or $0.79 per share and 11% of fiscal 2026 core EPS, capital spending is expected to be between 4.5% to 5.5% of sales, dividends are expected to exceed $10 billion, approximately $5 billion of common stock is expected to be repurchased, and the company plans to return $15 billion of cash to shareowners; P&G expects H1 to be at about 3% organic sales growth, with slight acceleration in half 2, and category value growth of 2.5% to 3%.